EVASON(HangZhou)Network Technology Co.,Ltd – Trademark Portfolio
Entity Type: 99
EVASON(HangZhou)Network Technology Co.,Ltd holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 7 (Machinery) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include HRLMP and M MOLLBOK. The owner is based in Hangzhou, Zhejiang,.
Rm.712, West Dongsha Chuangyi Building,
No.77 Tiancheng East Rd., Xiasha St.,
Hangzhou, Zhejiang, 310018 , CN
Showing of trademarks Trademarks
Trademark Classifications
EVASON(HangZhou)Network Technology Co.,Ltd's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does EVASON(HangZhou)Network Technology Co.,Ltd have?
EVASON(HangZhou)Network Technology Co.,Ltd has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.
What trademark classes does EVASON(HangZhou)Network Technology Co.,Ltd file in?
EVASON(HangZhou)Network Technology Co.,Ltd files trademarks across 2 Nice Classification classes. The most active classes are Class 7 (Machinery), Class 10 (Medical Apparatus). Class 7 covers machines and machine tools; motors and engines; machine coupling and transmission components.
What are EVASON(HangZhou)Network Technology Co.,Ltd's most well-known trademarks?
EVASON(HangZhou)Network Technology Co.,Ltd's registered trademark portfolio includes well-known marks such as HRLMP and M MOLLBOK. These are among 2 currently registered trademarks in the portfolio.
What is EVASON(HangZhou)Network Technology Co.,Ltd's trademark registration success rate?
EVASON(HangZhou)Network Technology Co.,Ltd has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.